metoprolol tartrate- metoprolol tartrate tablet, film coated
pd-rx pharmaceuticals, inc. - metoprolol tartrate (unii: w5s57y3a5l) (metoprolol - unii:geb06nhm23) - hypertension metoprolol tartrate tablets are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents. angina pectoris metoprolol tartrate tablets are indicated in the long-term treatment of angina pectoris. myocardial infarction metoprolol tartrate tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol. oral metoprolol tartrate tablets therapy can be initiated after intravenous metoprolol therapy or, alternatively, oral treatment can begin within 3 to 10 days of the acute event. (see dosage and administration, contraindications, and warnings). hypertension and angina metoprolol tartrate tablets are contraindicated in sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure (see warnings). hypersensitivity to metoprolol and related
carbidopa and levodopa tablet, extended release
alembic pharmaceuticals inc. - carbidopa (unii: mnx7r8c5vo) (carbidopa anhydrous - unii:kr87b45rgh), levodopa (unii: 46627o600j) (levodopa - unii:46627o600j) - carbidopa and levodopa extended-release tablets, usp are indicated in the treatment of parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. nonselective monoamine oxidase (mao) inhibitors are contraindicated for use with carbidopa and levodopa extended-release tablets. these inhibitors must be discontinued at least two weeks prior to initiating therapy with carbidopa and levodopa extended-release tablets. carbidopa and levodopa extended-release tablets may be administered concomitantly with the manufacturer’s recommended dose of an mao inhibitor with selectivity for mao type b (e.g., selegiline hcl) (see precautions, drug interactions ). carbidopa and levodopa extended-release tablets are contraindicated in patients with known hypersensitivity to any component of this drug, and in patients with narrow-angle glaucoma.
carbidopa and levodopa tablet, extended release
alembic pharmaceuticals limited - carbidopa (unii: mnx7r8c5vo) (carbidopa anhydrous - unii:kr87b45rgh), levodopa (unii: 46627o600j) (levodopa - unii:46627o600j) - carbidopa and levodopa extended-release tablets, usp are indicated in the treatment of parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. nonselective monoamine oxidase (mao) inhibitors are contraindicated for use with carbidopa and levodopa extended-release tablets. these inhibitors must be discontinued at least two weeks prior to initiating therapy with carbidopa and levodopa extended-release tablets. carbidopa and levodopa extended-release tablets may be administered concomitantly with the manufacturer’s recommended dose of an mao inhibitor with selectivity for mao type b (e.g., selegiline hcl) (see precautions, drug interactions ). carbidopa and levodopa extended-release tablets are contraindicated in patients with known hypersensitivity to any component of this drug, and in patients with narrow-angle glaucoma.
maalox stomach ache aluminium hydroxide/ magnesium hydroxide 460mg/400mg red berries,oral suspension
sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - aluminium hydroxide, magnesium hydroxide - oral suspension - magnesium hydroxide 400 mg aluminium hydroxide 460 mg - drugs for acid related disorders
gascid chewable tablets (aluminium hydroxide + magnesium trisilicate + simethicone)
healol pharmaceuticals sdn. bhd. - dried aluminium hydroxide; magnesium trisilicate; simethicone -
resmed aluminium hydroxide gel 200mg/5ml
resmed pharmaceuticals c.c - aluminium oxide - suspension - each 5ml of suspension contains aluminium oxide 200mg
lidocaine hydrochloride injection, solution
lifestar pharma llc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride injection is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and by peripheral nerve block techniques such as brachial plexus and intercostal, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hydrochloride is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
pepcid duo chewable tablets famotidine 10mg magnesium hydroxide 165mg calcium carbonate 800mg
jntl consumer health i (ireland) limited - famotidine; magnesium hydroxide; calcium carbonate - chewable tablet - h2-receptor antagonists; famotidine, combinations
aluminium acetate
penn pharmaceuticals ltd - aluminium sulfate acetic acid l-tartaric acid calcium carbonate purified water -
quickphos fumigation blanket
upl australia pty ltd - aluminium phosphide - sachet - aluminium phosphide mineral-aluminium active 570.0 g/kg - mixed function pesticide - grain storage area and/or facility | stored barley seed | stored breakfast cereal | stored bulk stock feed | stored cereal grain - angoumois grain moth | cadelle | cigarette beetle | coffee bean weevil | confused flour beetle | dried fruit beetle | flat grain beetle | flour beetles | granary weevil | hide or skin beetle | indian meal moth | lesser grain borer | maize weevil | mediterranean flour moth | merchant grain beetle | mottled grain moth | psocids or booklouse | raisin moth | redlegged ham beetle | rice weevil | sawtoothed grain beetle | spider beetle | stored product mite | tobacco moth | tropical warehouse moth | warehouse beetle | dermestes ater | dermestes maculatus | grain borer | tobacco beetle | tribolium castaneum | tribolium confusum | tribolium spp.